Impact BioMedical, Inc. (IBO) Stock Price

IBOStock

$0.44−24.46%52W

Market Cap$47.84M

P/E—

PEG Ratio—

Div yield—

Beta-1.23

IBO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-11.09%

Price vs S&P 500 (4W)-0.47%

VGM Score28.18

Book Value / Share (Quarterly)$0.11

Cash Flow / Share (Quarterly)$-0.02

Price vs S&P 500 (YTD)-24.96%

Net Profit Margin (TTM)-32969.23%

EPS (TTM)$-1.26

10-Day Avg Trading Volume0.03M

EPS Excl Extra (TTM)$-1.26

EPS (Annual)$-0.38

ROI (Annual)-89.48%

Gross Margin (Annual)84.38%

Cash / Share (Quarterly)$0.00

ROA (Last FY)-68.01%

EBITD / Share (TTM)$-0.08

ROE (5Y Avg)-143.73%

Operating Margin (TTM)-14256.41%

Cash Flow / Share (Annual)$-0.02

P/B Ratio4.14x

P/B Ratio (Quarterly)5.64x

Net Income / Employee (Annual)$-5,919,000

EV / Revenue (TTM)1244.21x

Net Interest Coverage (TTM)-0.42x

ROA (TTM)-71.67%

EPS Incl Extra (Annual)$-0.38

Current Ratio (Annual)0.35x

Quick Ratio (Quarterly)0.13x

3-Month Avg Trading Volume0.05M

52-Week Price Return-24.46%

Revenue / Employee (TTM)$19,500

Tangible BV / Share (Quarterly)$1.15

P/S Ratio (Annual)1482.54x

Asset Turnover (Annual)0.00x

52-Week High$0.83

EPS Excl Extra (Annual)$-0.38

26-Week Price Return0.84%

Quick Ratio (Annual)0.18x

13-Week Price Return-13.69%

Total Debt / Equity (Annual)0.05x

Current Ratio (Quarterly)0.22x

Enterprise Value$48.52M

Asset Turnover (TTM)0.00x

Revenue / Employee (Annual)$16,000

Pretax Margin (Annual)-45156.25%

Cash / Share (Annual)$0.00

3-Month Return Std Dev64.66%

Net Income / Employee (TTM)$-6,429,000

ROE (Last FY)-93.89%

Net Interest Coverage (Annual)-1.97x

EPS Basic Excl Extra (Annual)$-0.38

Receivables Turnover (TTM)19.50x

Total Debt / Equity (Quarterly)0.10x

EPS Incl Extra (TTM)$-1.26

ROI (TTM)22.93%

P/S Ratio (TTM)1216.44x

Revenue / Share (Annual)$0.00

Price vs S&P 500 (52W)-43.02%

Year-to-Date Return-12.14%

5-Day Price Return-2.05%

EPS Normalized (Annual)$-0.38

ROA (5Y Avg)-43.39%

Net Profit Margin (Annual)-36993.75%

Month-to-Date Return3.19%

EBITD / Share (Annual)$-0.10

Operating Margin (Annual)-13381.25%

ROI (5Y Avg)-61.93%

LT Debt / Equity (Quarterly)0.25x

EPS Basic Excl Extra (TTM)$-1.26

P/TBV (Quarterly)1.73x

P/B Ratio (Annual)0.49x

Pretax Margin (TTM)-39630.77%

Book Value / Share (Annual)$0.12

Price vs S&P 500 (13W)-15.65%

Beta-1.23x

Revenue / Share (TTM)$0.00

ROE (TTM)24.58%

52-Week Low$0.37

vGradeF

mGradeD

vgmGradeD

Industry Peers — Pharmaceuticals(570)

Symbol	Value Score	Growth Score	Momentum Score	Price
IBOImpact BioMedical, Inc.	F	—	D	$0.44
LLYEli Lilly & Co.	D	B	C	$1174.61
JNJJohnson & Johnson	D	C	B	$268.04
ABBVABBVIE INC.	D	C	B	$255.48
MRKMerck & Co., Inc.	D	C	B	$148.35
NVSNovartis AG	C	C	C	$153.81
AZNAstraZeneca PLC	C	B	C	$162.70
NVONovo-Nordisk A/S	B	C	C	$45.61
ABTAbbott Laboratories	C	C	C	$112.47
PFEPfizer Inc.	C	D	B	$27.96
VRTXVertex Pharmaceuticals Inc	D	C	B	$541.69
BMYBristol-Myers Squibb Co.	B	B	B	$66.58
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$44.82
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$50.82
REGNRegeneron Pharmaceuticals Inc	C	C	B	$794.19
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	B	$18.03
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$36.44
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	$366.73
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$60.85
ZTSZOETIS INC.	C	C	D	$77.34
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$237.10
INSMInsmed, Inc.	F	A	C	$118.54
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$34.71
UTHRUnited Therapeutics Corp	C	C	B	$515.46
GMABGenmab A/S ADS	C	C	B	$33.23
VTRSViatris Inc. Common Stock	B	C	B	$16.34
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$247.91
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$244.54
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$76.60
BMRNBioMarin Pharmaceuticals Inc	C	C	B	$64.67
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	B	$533.76
CORTCorcept Therapeutics Inc.	F	C	B	$113.88
ELANElanco Animal Health Incorporated Common Stock	C	B	C	$24.11
ARWRArrowhead Research Corporation	D	A	B	$84.91
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.73
AXSMAxsome Therapeutics, Inc	D	B	C	$199.02
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.18
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$61.05
CYTKCytokinetics Inc.	F	D	C	$72.09
ABVXAbivax SA American Depositary Shares	—	—	C	$113.35
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$344.75
PTGXProtagonist Therapeutics, Inc	F	B	B	$144.33
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.84
TGTXTG Therapeutics, Inc.	D	B	B	$53.93
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	$90.36
ALKSAlkermes Inc. plc	D	C	B	$47.41
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$107.17
ERASErasca, Inc. Common Stock	—	—	A	$18.03
TVTXTravere Therapeutics, Inc. Common Stock	F	B	A	$65.67
BLTEBelite Bio, Inc American Depositary Shares	—	—	C	$151.72

About Impact BioMedical, Inc.

Impact BioMedical Inc develops therapeutics and preventative solutions targeting neurological, oncological, and immune-related diseases. The company also advances open-air defense technologies designed to reduce transmission of airborne infectious diseases, including tuberculosis and influenza. Its proprietary platforms include Linebacker, Laetose, 3F, and Equivir.